Category: Business

HIGHLIGHTS

• Completes first two drill holes of its 2025 Angilak Exploration Program comprising ~10,000m of diamond drilling.

• KU Discovery Target:

  • The maiden drill hole, KU-DD-001 successfully targeted stacked gravity and structural anomalies (Figure 2), intersecting shallow high-grade uranium mineralization as well as numerous zones of lower-grade mineralization throughout the hole. The hole intersected total composite mineralization of 7.1 m, including a continuous shallow zone (between 84.95 m and 87.45 m) of 0.7 m of high-grade mineralization that had max radioactivity up to 18,490 CPS (Figures 3 & 4).

  • The initial drilling at the KU Discovery Target confirms the Company’s thesis that the 31 km long RIB-Nine Iron corridor is prospective for hosting uranium mineralization within the Angikuni Basin.

  • The KU Discovery target is located within the Angikuni Basin, approximately 3 km from the northern margin, where historical trench sampling returned grades up to 30.7% U ₃ O ₈ .

  • In May 2025, ATHA completed a ground gravity and electromagnetic (EM) survey, designed to vector in on priority targets along the highly prospective 31 km Rib-Nine Iron Trend, under cover of the Angikuni Basin – a direct analog to the Athabasca Basin.

  • At KU, the survey identified a large – 2 km long by 500 m wide geophysical gravity anomaly. Additionally, a geological structural study was completed in May by SRK Consulting, highlighting numerous interpreted NW-SE faults and cross cutting E-W faults. The gravity survey demonstrates the identified anomalies are coincident with the modeled faults, and the historical high-grade surficial mineralization.

• Lac 50 Deposit:

  • The first hole targeted the J4/Ray zones located along the Lac 50 Trend (Figure 2). The hole successfully extended mineralization down-dip by ~100 m, demonstrating that the Lac 50 Deposit remains open and unconstrained, both along strike and at depth.

  • J4R-DD-0091 intersected 3.8 m of composite mineralization including 0.4 m of >10,000 CPS up to a max of 14,826 CPS (Figure 5).

  • The 2025 Angilak Exploration Program will continue to target expansion of the mineralized envelop at the Lac 50 Deposit while also testing regional targets along the RIB-Nine Iron Corridor.

Troy Boisjoli, CEO commented: “ The results from our first two diamond drill holes completed as part of the 2025 Angilak Exploration Program highlight two things. First, the robust metal endowment at the Angilak Uranium Project, and second, the successful systematic exploration approach of our world class technical team. The discovery of a new zone of mineralization on a maiden drill hole in a new area and the continued expansion at the Lac 50 Deposit is truly remarkable. Both confirm the Company’s exploration thesis, substantially derisking the numerous prospective regional targets, providing a roadmap for executing on successful discoveries. All this at a time when the macro thesis for uranium as the fuel for the New Nuclear Renaissance is top of mind for the world. ATHA Energy and our Angilak Project is well positioned to be a critical player in this cycle.”

Cliff Revering, VP Exploration added: “ Since acquiring the Angilak Project in April 2024, we have focused on developing our understanding of the regional geology, structural architecture and mineralization controls within the Lac 50 Deposit area and Angikuni Basin. As a result, our first hole in the KU target area not only intersected a significant mineralized structural corridor, but also a large graphitic fault breccia zone displaying substantial vertical displacement of the basin unconformity – geological conditions which are extremely favorable for deposition of unconformity-related uranium mineralization. Our thesis of the Angikuni Basin being an emerging uranium district and highly prospective for discovery of additional uranium deposits continues to unfold. “

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / June 24, 2025 / ATHA Energy Corp. (TSX.V:SASK)(FRA:X5U)(OTCQB:SASKF) (“ATHA” or the “Company“), is pleased to announce results for the first two diamond drill holes completed as part its 2025 Angilak diamond drill exploration program at its 100%-owned Angilak Uranium Project, Nunavut.

The maiden drill hole at the KU Discovery Target intersected five zones of uranium mineralization, including a shallow high-grade lense. The results demonstrate the Company’s thesis that the Angikuni Basin is a direct analog to the Athabasca Basin, and that the 31 km RIB-Nine Iron Trend remains prospective for additional discoveries. At the Lac 50 Deposit, the first hole drilled at the J4/Ray Zone along the Lac 50 Trend intersected four zones of uranium mineralization, expanding the down-dip extents of the envelop of mineralization. J4R-DD-091 demonstrates that the Lac 50 Deposit remains open and unconstrained.

Figure 1: Angilak Project Area – 2025 Exploration Target Area (Black Rectangles) & Mapped Historic

*Notes:

^I Previous operators of the Angilak Project completed 24 diamond drill holes in the Dipole Showing and intersected grades of up to 5.53% U₃O₈ over 0.5 m³

^II Along the western margin, historic drilling at the RIB Discovery intersected shallow (<25 m depth>3O₈¹, hosted within graphitic pelitic rocks with Athabasca style alteration

^III Mushroom Lake surface outcrop spans an area of 3 km on surface with historical outcrops samples grading up to 47.8% U₃O₈^{4 & 6}

^IV Nine-Iron showing with 5 historical diamond drill holes. Intersections of shallow uranium mineralization, grades up to 1.25% U₃O₈ and historical outcrops with grades up to 30.3% U₃O₈³

Figure 2: Angilak Project Area – 2025 Drill Collar Locations

Table 1: 2025 Angilak Exploration Program Drill Collar Information

Hole ID	Trend	Zone	Azimuth (°)	Dip (°)	Easting (mE)	Northing (mN)	Elevation (m)	Final Depth (m)
KU-DD-001	RIB-Nine Iron	KU Target	30	70	515830	6936190	256.5	599
J4R-DD-091	Lac 50	J4/Ray	25	57	522295	6938558	218.0	650

Figure 3: KU-DD-001 Cross-section displaying interpreted structure and downhole drill results

Figure 4: Striplog KU-DD-001

Figure 5: Striplog J4R-DD-091

Disclaimer for Historical Drilling and Outcrop Samples

Certain noted technical information provided herein has been derived exclusively and without independent verification from the following reports. Such information is historical in nature and is not considered by the Company to be current. In each case, the reliability of the historical information is considered reasonable by the Company. The historical information provides an indication of the exploration potential of the properties but may not be representative of expected results. Readers should read the entirety of such noted reports to fully understand the nature of the information referenced herein. Samples, including, without limitation, outcrop samples, by their nature, are selective in nature and significant variations may be seen from sample to sample. Accordingly, sample information may not be representative of the true underlying mineralization.

References for Historic Diamond Drilling Results

1. Papish, N.Z. 1978. 1978 Diamond Drill Report, Keewatin District N.W.T. Yathkyed Lake Area. Noranda Exploration company Assessment Report. March 6, 1979. A copy of such report is available on the website of the Government of Nunavut at https://nunavutgeoscience.ca/en/.

2. Dufresne, M.B., Sim, R. and Davis B., (2013). Technical report And Resource Update for the Angilak Project, Kivalliq Region, Nunavut. Technical Report prepared on behalf of Kivalliq Energy Corporation, March 1st, 2013. A copy of such report is available on the SEDAR+ profile of Kivalliq Energy Corporation at www.sedarplus.com.

3. Dufresne, M.B. and Schoeman, P. (2023). Technical report on the Angilak Project, Kivalliq Region, Nunavut. Technical Report prepared on behalf of ATHA Energy Corp. and Labrador Uranium Inc., January 31^st, 2024. A copy of such report is available on the SEDAR+ profile of the Company at www.sedarplus.com.

References for Historic Surficial Sampling

4. Ward, j., Maynes, A., McNie, E., Forbes, A. and Stacey, J. 2012. Report on 2010 and 2011 Exploration Activity on Kivalliq Corporation’s Angilak IOCG-Uranium Property, Keewatin District, Nunavut. Kivalliq Energy Corporation Assessment Report. A copy of such report is available on the website of the Government of Nunavut at https://nunavutgeoscience.ca/en/.

5. Dufresne, M.B., Sim, R. and Davis B., (2013). Technical report And Resource Update for the Angilak Project, Kivalliq Region, Nunavut. Technical Report prepared on behalf of Kivalliq Energy Corporation, March 1st, 2013. Copy of such report is available on the SEDAR+ profile of Kivalliq Energy Corporation at www.sedarplus.com

6. Dufresne, M.B. and Schoeman, P. (2023). Technical report on the Angilak Project, Kivalliq Region, Nunavut. Technical Report prepared on behalf of ATHA Energy Corp. and Labrador Uranium Inc., January 31, 2024. A copy of such report is available on the SEDAR+ profile of the Company at www.sedarplus.com.

Qualified Person

The scientific and technical information contained in this news release have been reviewed and approved by Cliff Revering, P.Eng., Vice President, Exploration of ATHA, who is a “qualified person” as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

About ATHA

ATHA is a Canadian mineral company engaged in the acquisition, exploration, and development of uranium assets in the pursuit of a clean energy future. With a strategically balanced portfolio including three 100%-owned post discovery uranium projects (the Angilak Project located in Nunavut, and CMB Discoveries in Labrador, and the newly discovered basement hosted GMZ high-grade uranium discovery located in the Athabasca Basin). In addition, the Company holds the largest cumulative prospective exploration land package (>7 million acres) in two of the world’s most prominent basins for uranium discoveries – ATHA is well positioned to drive value. ATHA also holds a 10% carried interest in key Athabasca Basin exploration projects operated by NexGen Energy Ltd. and IsoEnergy Ltd. For more information visit www.athaenergy.com.

On Behalf of the Board of Directors

Troy Boisjoli, CEO, ATHA Energy Corp

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Troy Boisjoli
Chief Executive Officer
Email: info@athaenergy.com
www.athaenergy.com
1-236-521-0526

Cautionary Statement Regarding Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These forward-looking statements or information may relate to ATHA’s proposed exploration program, including statements with respect to the expected benefits of ATHA’s proposed exploration program, any results that may be derived from ATHA’s proposed exploration program, the timing, scope, nature, breadth and other information related to ATHA’s proposed exploration program, any results that may be derived from the diversification of ATHA’s portfolio, the prospects of ATHA’s projects, including mineral resources estimates and mineralization of each project, the prospects of ATHA’s business plans and any expectations with respect to defining mineral resources or mineral reserves on any of ATHA’s projects, and any expectation with respect to any permitting, development or other work that may be required to bring any of the projects into development or production.

Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management at the time, are inherently subject to business, market and economic risks, uncertainties and contingencies that may cause actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements. Such assumptions include, but are not limited to, assumptions that the anticipated benefits of ATHA’s proposed exploration program will be realized, that no additional permit or licenses will be required in connection with ATHA’s exploration programs, the ability of ATHA to complete its exploration activities as currently expected and on the current anticipated timelines, including ATHA’s proposed exploration program, that ATHA will be able to execute on its current plans, that ATHA’s proposed explorations will yield results as expected, and that general business and economic conditions will not change in a material adverse manner. Although ATHA has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information.

Such statements represent the current view of ATHA with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by ATHA, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Risks and uncertainties include, but are not limited to the following: inability of ATHA to realize the benefits anticipated from the exploration and drilling targets described herein or elsewhere; in ability of ATHA to complete current exploration plans as presently anticipated or at all; inability for ATHA to economically realize on the benefits, if any, derived from the exploration program; failure to complete business plans as it currently anticipated; overdiversification of ATHA’s portfolio; failure to realize on benefits, if any, of a diversified portfolio; unanticipated changes in market price for ATHA shares; changes to ATHA’s current and future business and exploration plans and the strategic alternatives available thereto; growth prospects and outlook of the business of ATHA; and the ability to advance the Company projects and its proposed exploration program; risks inherent in mineral exploration including risks related worker safety, weather and other natural occurrences, accidents, availability of personnel and equipment, and other factors; aboriginal title; failure to obtain regulatory and permitting approvals; no known mineral resources/reserves; reliance on key management and other personnel; competition; changes in laws and regulations; uninsurable risks; delays in governmental and other approvals, community relations; stock market conditions generally; demand, supply and pricing for uranium; and general economic and political conditions in Canada, Australia and other jurisdictions where ATHA conducts business. Other factors which could materially affect such forward-looking information are described in the filings of ATHA with the Canadian securities regulators which are available on ATHA’s profile on SEDAR+ at www.sedarplus.ca. ATHA does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

SOURCE: ATHA Energy Corp

View the original press release on ACCESS Newswire

TORONTO, ON / ACCESS Newswire / June 24, 2025 / Eskay Mining Corp. (“Eskay” or the “Company”) (TSXV:ESK)(OTC PINK:ESKYF)(Frankfurt:KN7)(WKN:A0YDPM) wishes to announce that an aggregate of 5,200,000 options to purchase common shares of Eskay at $0.385 per share for five years have been granted to five directors and three consultants of Eskay. The grant is subject to acceptance by the TSX Venture Exchange.

About Eskay Mining Corp:
Eskay Mining Corp (TSXV:ESK) is a TSX Venture Exchange listed company, headquartered in Toronto, Ontario. Eskay is an exploration company focused on the exploration and development of precious and base metals along the Eskay rift in a highly prolific region of northwest British Columbia known as the “Golden Triangle,” 70km northwest of Stewart, BC. The Company currently holds mineral tenures in this area comprised of 177 claims (52,600 hectares).

All material information on the Company may be found on its website at www.eskaymining.com and on SEDAR+ at www.sedarplus.com.

For further information, please contact:

Mac Balkam		T: 416 907 4020
President & Chief Executive Officer		E: Mac@eskaymining.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements: This Press Release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties. Many factors could cause our actual results to differ materially from the statements made, including those factors discussed in filings made by us with the Canadian securities regulatory authorities. Should one or more of these risks and uncertainties, such as actual results of current exploration programs, the general risks associated with the mining industry, the price of gold and other metals, currency and interest rate fluctuations, increased competition and general economic and market factors, occur or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to put undue reliance on such forward-looking statements.

SOURCE: Eskay Mining Corp.

View the original press release on ACCESS Newswire

INDIANAPOLIS, IN AND GURUGRAM, INDIA / ACCESS Newswire / June 24, 2025 / Arrive AI (NASDAQ:ARAI) – a pioneering autonomous delivery network anchored by Arrive Points™ – today announced a new global customer: Skye Air Mobility , India’s dominant and rapidly expanding hyperlocal delivery platform. This expected partnership marks a pivotal moment, scaling secure, automated delivery solutions across one of the world’s most dynamic markets.

Skye Air currently offers 7-minute drone delivery to customers in Gurugram, part of NCR (National Capital Region) of Delhi and Bengaluru (Karnataka), making about 6,000 deliveries per day. The partnership entails co-developing mailboxes and installing across the country. Arrive AI shall begin from the initial 60 units being placed in Gurugram followed by other cities as per Skye Air’s expansion plan. Both companies expect to have 500 Arrive Points across Skye Air’s service areas in the future, serving a New Delhi population exceeding 33 million.

“The population density and scalability opportunity – along with huge demand for drone delivery from Indian consumers and governmental policies that encourage drone delivery – creates an unparalleled chance for us to showcase the transformative power of Arrive AI,” said Arrive AI Founder and CEO Dan O’Toole. “This isn’t just about delivery; it’s about establishing a universally trusted custody layer for autonomous logistics and allows us to grow rapidly in a one-billion-plus population country that is already moving fast on autonomy.”

Arrive AI’s industry-first patents underscore its evolution from a “smart mailbox” to a comprehensive autonomous delivery network and platform company. Arrive Points are secure, app-accessible mini cross docks, and offer a significantly elevated level of security compared to current delivery points, establishing a crucial trusted custody layer for real-world networks and asynchronous access.

Ankit Kumar, Skye Air, Founder & CEO, highlighted the synergy by saying, “Skye Air is on the forefront of drone delivery technology having built to deliver at scale. The company is already delivering about 200,000 packages on a monthly basis, just in one city. We believe Infrastructure is the most critical piece to scale drone delivery across the country, this is the reason we keep on investing in developing infrastructure. With access of 60-plus residential and commercial complexes in Gurugram, we are poised to shape the future of autonomous deliveries in India.”

“Our partnership with Arrive AI couldn’t have come at a time better than this, when we are scaling up operations and expanding to newer cities such as Bengaluru,” he continued. “Together with Arrive AI’s state-of-the-art product, we are certain to dominate the infrastructure access points. It will make the entire process so much better. We can’t wait to get these units in the field.”

Kiran Paul, who focuses on international business development for Arrive AI, was instrumental in setting up the strategic partnership.

“We anticipate that once we are operating in India and demonstrating the advantages Arrive Points offer, other countries looking to a future of increasing demand for quick, secure, drone-based ecommerce solutions will see the advantage of building Arrive Points into their smart city infrastructure plans, ” Paul said.

Arrive AI expects Arrive Points to be delivered to Skye Air within calendar year 2025.

Beyond technological alignment, both companies share a profound commitment to sustainable delivery. Each drone delivery via Skye Air reduces carbon emissions by 520 grams compared to traditional methods, translating to over 2.6 metric tons of carbon dioxide saved monthly. This partnership not only enhances drone capabilities for Skye Air’s current fleet of more than 30 drones but also lays crucial groundwork for seamless future integration with ground robotic deliveries.

-30-

About Arrive AI: Arrive AI’s patented last mile platform enables autonomous and human mail delivery to and from a physical hub, while providing tracking data, smart logistics alerts and advanced chain-of-custody controls to secure the last-mile delivery for all shippers, delivery services and autonomous delivery networks. Arrive AI makes the exchange of goods between people, robots, and drones frictionless, efficient, and convenient through artificial intelligence, autonomous technology, and interoperability with smart devices including doorbells, lighting and security systems. Learn more details about company patents here. See videos of the smart mailbox in action here.

Media contact: Cheryl Reed at media@arriveai.com

Investor Relations Contact: Alliance Advisors IR at ARAI.IR@allianceadvisors.com

About Skye Air: Skye Air is India’s fastest hyperlocal drone delivery network, pioneering last-mile logistics with its proprietary Drone and Skye UTM platform. With a focus on healthcare, e-commerce, quick commerce, and agri-commodity deliveries, Skye Air is at the forefront of sustainable, technology-driven logistics solutions. Driven by a mission deeply rooted in service to the nation, Skye Air pioneers’ drone-based last-mile delivery solutions that not only propel the logistics industry forward but also foster economic prosperity and accessibility nationwide. Positioned as a cornerstone of India’s evolving delivery ecosystem, Skye Air’s initiatives unlock opportunities and transform lives for millions of Indians. For more information, visit www.skyeair.tech

Cautionary Note Regarding Forward Looking Statements

This news release and statements of Arrive AI’s management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “potential”, “will”, “should”, “could”, “would”, “optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI’s Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov . Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

SOURCE: Arrive AI Inc.

View the original press release on ACCESS Newswire

ST. LOUIS, MO / ACCESS Newswire / June 23, 2025 / Kennedy Capital Management LLC (KCM), a specialist in micro, small, and mid-cap investment management services, is proud to announce that its small cap value fund (KVALX) has received an initial 4-Star¹ overall Morningstar Rating™. This total return achievement is measured against 477 funds in Morningstar’s Small Cap Value Category as of May 31, 2025, and is calculated based on Morningstar Risk-Adjusted Returns. This recognition underscore Kennedy’s commitment to delivering strong, risk-adjusted returns over time.

The 4-star rating for KVALX is particularly significant given the long-standing success of its underlying investment strategy, which has been a cornerstone of our firm since 1983. The fund benefits from the adept management of Frank Latuda, Jr., CFA^®, who has guided the strategy for over two decades, and McAfee Burke, CFA^®, who has brought valuable perspective and experience to the portfolio management team in recent years. While the strategy was made available in a mutual fund format in 2022, this Morningstar rating validates its enduring strength and success across both the institutional and retail worlds. Furthermore, as per the NADSAQ² eVestment™ database, the Small Cap Value strategy ranks in the top quartile for the 1, 3, 5, and 10-year periods ending March 31, 2025, highlighting its consistent outperformance over time.

KVALX benefits from the experience of a dedicated centralized team of research analysts. This cohesive team employs a fundamental, bottom-up investment approach, meticulously investigating individual companies within their investable universe. Under the guidance of Mr. Latuda and Mr. Burke, the fund seeks to identify companies across the value spectrum with favorable cash flow values relative to their current market capitalization, aiming for a portfolio with valuations below and growth characteristics at or above those of the benchmark.

“We established KVALX with investor demand in mind. The underlying strategy, professionally managed by Frank and McAfee, has long been available to institutional investors but has now been opened up to others,” says Don Cobin, CFA^®, CEO of KCM. “Achieving a 4-star¹ rating for our small cap value fund is a testament to the skill and dedication of our investment team and the consistent application of our disciplined research process. We are proud to offer investors a range of compelling options within the equity space.”

About Kennedy Capital Management LLC

Founded in 1980, St. Louis-based Kennedy Capital Management LLC delivers investment strategies to corporate and public pension funds, endowments, foundations, multi-employer plans, and high-net-worth individuals. As of March 31^st, 2025, KCM managed $4.5 billion in assets. The privately held registered investment adviser specializes in the management of small and mid-cap strategies across the growth-value spectrum. KCM integrates environmental, social, and governance (ESG) considerations into its research process and has nearly 20 years’ experience managing socially responsible client accounts. For more information, visit www.kennedycapital.com or email funds@kennedycapital.com.

¹Past performance is no guarantee of future results. Rating reflects fee waivers in effect; in their absence, the rating may have been lower.

Investors should consider the Funds’ investment objectives, risks, charges, and expenses carefully before investing. This and other important information is contained in the Funds’ full prospectuses and summary prospectuses, which can be obtained by visiting www.kennedycapital.com or by calling (833) 737-7788. Please read carefully before investing.

Important Risk Information: Equity securities (stocks) are generally more volatile and carry more risk than fixed income securities (bonds) and money market investments. The net asset value per share of the Small Cap Value fund (the Fund) will fluctuate as the value of the securities in the portfolio changes. Common stocks, and funds investing in common stocks, generally provide greater returns over long time periods than fixed income securities. The Fund is comprised primarily of equity securities and is subject to market risk. Stocks may decline due to general market and economic conditions or due to company specific circumstances. The Fund is comprised of small capitalization (“small cap”) stocks. Small cap stocks typically carry additional risk, since smaller companies generally have a higher risk of failure, and historically have experienced a greater degree of volatility. Small capitalization companies generally have a greater risk of failure, and their stocks generally have greater volatility than large companies. Mutual fund investing involves risk, including loss of principal.

Risks specific to KVALX: Value investing is subject to the risk that the market will not recognize a security’s inherent value for a long time or at all.

Index definitions and technical terms:

The Russell 2000^® Value Index is used as the benchmark for the Kennedy Capital Small Cap Value Fund and strategy. The Russell 2000^® Value Index measures the performance of small-cap value segment of the U.S. equity universe. It includes those Russell 2000 companies with relatively lower price-to-book ratios, lower I/B/E/S forecast medium term (2 year) growth and lower sales per share historical growth (5 year). The Russell 2000^® Value Index is constructed to provide a comprehensive and unbiased barometer for the small-cap value segment. The Index is completely reconstituted annually to ensure new and growing equites are included and that the represented companies continue to reflect value characteristics. You cannot invest directly into an index.

© 2025 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The Morningstar Rating^TM for funds, or “star rating”, is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product’s monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The Morningstar Rating does not include any adjustment for sales loads. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10- 3 year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods. As of 5/31/25, KVALX was rated against 477 Small Value funds for the 3-year period. KVALX received 4 stars for this period. The Small Value category includes funds that typically invest in small US companies with valuations and growth rates below other small-cap peers. Stocks in the bottom 10% of the capitalization of the US equity market are defined as small cap. Value is defined based on low valuations (low price ratios and high dividend yields) and slow growth (low growth rates for earnings, sales, book value, and cash flow).

²eVestment and its affiliated entities (collectively, “eVestment”) collect information directly from investment management firms and other sources believed to be reliable; however, eVestment does not guarantee or warrant the accuracy, timeliness, or completeness of the information provided and is not responsible for any errors or omissions. Performance results may be provided with additional disclosures available on eVestment’s systems and other important considerations such as fees that may be applicable.

Kennedy Capital Management LLC is an investment adviser registered with the U.S. Securities and Exchange Commission and the adviser to the Funds.

The Funds are distributed by IMST Distributors, LLC.

Safe Harbor Statement

This press release is not intended as a recommendation or as investment advice of any kind, shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction. All content has been provided for informational or educational purposes only.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains certain statements that may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, included herein are “forward-looking statements.” Although Kennedy Capital Management LLC believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Fund’s reports that are filed with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required by law, Kennedy Capital Management, Inc. does not assume a duty to update this forward-looking statement. 2025060024

Contact

Sarah Burkemper
sburkemper@kennedycapital.com
(314) 743-8221

SOURCE: Kennedy Capital Management, Inc.

View the original press release on ACCESS Newswire

Designed to combine sustainability, flexibility, and seamless user experience.

DUBAI, UNITED ARAB EMIRATES / ACCESS Newswire / June 23, 2025 / In a landmark partnership set to reshape the region’s telecom landscape, Basatne MENA, the regional arm of global circular economy leader Basatne, has partnered with Likewize, the global leader in device lifecycle services, to launch ‘Upgrade & Protect’, the Middle East’s first subscription-based smartphone program designed to combine sustainability, flexibility, and seamless user experience.

With smartphone users in the GCC replacing devices every 12-18 months and over 50 million active handsets in circulation, ‘Upgrade & Protect’ transforms traditional instalment plans into a dynamic monthly subscription that empowers consumers to swap, upgrade, or protect their devices anytime. For telcos, the model unlocks new recurring revenue streams while aligning with growing ESG mandates.

This innovation arrives at a pivotal time, with UAE and GCC markets moving rapidly toward Net Zero and green digital transformation. The program aligns closely with the UAE’s Net Zero by 2050 Strategy and the GSMA’s Circular Economy for Mobile Devices initiative, supporting a shift away from linear consumption toward a more regenerative, technology-enabled future.

An Integrated Ecosystem Powering Circular Innovation ‘Upgrade & Protect’ is enabled by Basatne’s regional infrastructure, combining the power of Cartlow’s re-commerce and trade-in platform with Ardroid’s AI-powered reverse logistics engine. Together, they provide telcos with a complete circular framework, from seamless device collection and grading to resale, refurbishment, and responsible recycling.

Likewize brings its global expertise to ensure scalability and telco readiness. Its risk-free operational model gives mobile operators access to a full turnkey solution with measurable economic returns and environmental impact.

The Market Opportunity

The GCC is primed for the shift to device-as-a-service models:

• Smartphone penetration exceeds 90% across GCC markets.

• Handset replacement cycles average 12-18 months, creating strong upgrade demand.

• The global device subscription market is projected to exceed USD 25 billion by 2027.

• By 2026, 5G adoption is expected to cover 73% of GCC mobile subscriptions.

• The regional smartphone market is forecasted to grow from 60 million units in 2024 to nearly 99 million by 2033.

“Our partnership with Likewize marks a pivotal evolution in device ownership across the Middle East,” said Mahmoud Abusway, Chief Commercial Officer of Basatne MENA. “By embedding circular economy principles into the telco model, ‘Upgrade & Protect’ delivers a flexible, sustainable solution that reduces waste, maximises asset value, and transforms the device lifecycle for both consumers and operators.”

With this program, Basatne MENA and Likewize are setting a new benchmark for telecom innovation in the region, one that blends sustainability, digitisation, and consumer empowerment. ‘Upgrade & Protect’ is not just a service; it represents a shift in how the region thinks about technology ownership and circular value creation.

About Basatne

Basatne is a global leader in circular technology, sustainable trade solutions, and reverse logistics, dedicated to reshaping the future of commerce. Through proprietary platforms, advanced logistics, and strategic partnerships, Basatne extends product lifecycles, reduces environmental impact, and optimizes global supply chains. Operating across six continents, Basatne is committed to delivering smarter, more responsible trade solutions while driving innovation in the circular economy. For more information, visit www.basatne.com.

For media inquiries, please contact:
Nick Jankowski, CMO
nick@basatne.com or info@basatne.com
469-646-0949

SOURCE: Basatne

View the original press release on ACCESS Newswire

Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pediatric patients has reached approximately 25%

As recently announced, initial proof-of-concept results of the ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in patients with intestinal failure due to MVID and short bowel syndrome by up to 27% and 12.5% respectively; data from the third patient enrolled is expected

Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar’s intestinal failure products, resulting in non-dilutive funding for Jaguar

SAN FRANCISCO, CA / ACCESS Newswire / June 23, 2025 / Jaguar Health, Inc.(NASDAQ:JAGX) (Jaguar) today provided updates on the company’s orphan disease intestinal failure program. Jaguar, through Jaguar family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics, is currently supporting two independent proof-of-concept investigator-initiated trials (IITs), and conducting two placebo-controlled Phase 2 studies, of crofelemer, Jaguar’s novel plant-based anti-secretory prescription drug, in patients with intestinal failure due to microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF) in the United States, European Union, and/or Middle East/North Africa regions.

As announced, and as presented April 26, 2025 at the Annual ELITE PED-GI Congress, initial proof-of-concept results from the ongoing exploratory, single-arm open label non-randomized IIT of crofelemer in Abu Dhabi in pediatric intestinal failure patients show that crofelemer reduced the required total parenteral nutrition (TPN) and supplementary intravenous fluids in the first participating MVID patient by up to 27% and in the first participating SBS-IF patient by up to 12.5%. In addition, this data showed that crofelemer reduced stool volume output and/or frequency of watery stools, and increased urine output – an indicator of improved nutrient oral absorption. Data from the third patient enrolled in the IIT is expected.

Completion of Napo’s randomized double-blind, placebo-controlled Phase 2 study of crofelemer in pediatric MVID patients is expected in mid-2026 as planned.

“Our strategy is to seek business development partnerships for license rights for development and commercialization of Jaguar’s intestinal failure products – with the goal of generating non-dilutive funding for Jaguar,” said Lisa Conte, Jaguar’s Founder and CEO. “I attended the BIO International Convention in Boston last week and took part in productive meetings at the event.”

“Given the ultrarare nature of MVID, and the groundbreaking initial proof-of-concept results from the ongoing IIT in Abu Dhabi, even a small number of MVID patients showing benefit with crofelemer may allow Napo to explore pathways for expedited regulatory approval,” said Conte.

“We’re excited to report that enrollment in the company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for MVID in pediatric patients is at approximately 25% and patient screening is continuing. For the company’s placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for SBS-IF in adults, enrollment is above 10%, and patient screening is continuing,” said Conte. “Additionally, enrollment is continuing in the two ongoing proof-of-concept IITs. These are important milestones in development efforts for crofelemer for the treatment and management of intestinal failure related to these devastating orphan diseases and will continue to generate IIT data.”

Based on the initial findings of the ongoing IIT in Abu Dhabi, crofelemer’s paradigm-shifting antisecretory mechanism of action appears to have the potential to provide a novel therapeutic option to reduce TPN and associated complications, including liver, renal, and cognitive deficits, as well as infections from IV infusion, in patients with intestinal failure due to MVID and short bowel syndrome. The observed groundbreaking TPN reduction is particularly compelling for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid management and for which no approved drug treatments exist, or any potential approach to reduce TPN.

The initial proof-of-concept data in MVID supports crofelemer’s potential inclusion in the European Medicines Agency’s (EMA) PRIMEprogram that may accelerate regulatory approval pathways in the EU. This data may also support qualification of crofelemer for the FDA’s Breakthrough Therapyprogram for expedited regulatory approval in the US. Additional proof-of-concept results from IITs are expected throughout 2025 and will provide additional preliminary data on the safety and potential effectiveness of crofelemer for these highly unmet clinical needs. In accordance with the guidelines of specific EU countries, published data from clinical investigations in MVID and SBS-IF could support reimbursed early patient access to crofelemer for these debilitating conditions.

About Crofelemer
Crofelemer is a novel, oral plant-based prescription medicine purified from the red bark sap, also referred to as “dragon’s blood,” of the Croton lechleri tree in the Amazon Rainforest. Napo Pharmaceuticals has established a sustainable harvesting program, under fair trade practices, for crofelemer to ensure a high degree of quality, ecological integrity, and support for indigenous communities.

About the Jaguar Health Family of Companies
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar’s Entheogen Therapeutics Initiative(ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.

For more information about:
Jaguar Health, visit https://jaguar.health/
Napo Pharmaceuticals, visit www.napopharma.com
Napo Therapeutics, visit napotherapeutics.com
Magdalena Biosciences, visit magdalenabiosciences.com

Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram

Forward-Looking Statements
Certain statements in this press release constitute “forward-looking statements.” These include statements regarding Jaguar’s expectation that completion of Napo’s Phase 2 study of crofelemer in pediatric MVID patients will occur mid-2026, Jaguar’s expectation that the two ongoing proof-of-concept IITs will continue to generate data, Jaguar’s expectation that data from the third patient enrolled in the IIT in Abu Dhabi is expected, Jaguar’s expectation that its strategy of seeking business development partnerships for license rights for development and commercialization of Jaguar’s intestinal failure products may support generation of non-dilutive funding for Jaguar, Jaguar’s expectation that even a small number of MVID patients showing benefit with crofelemer may allow Napo to explore pathways for expedited regulatory approval of crofelemer for MVID, Jaguar’s expectation that crofelemer’s mechanism of action may have the potential to provide a novel therapeutic option to reduce TPN and associated complications, including liver, renal, and cognitive deficits, as well as infections from IV infusion, in pediatric MVID and SBS-IF patients, Jaguar’s expectation that proof-of-concept data in MVID may support crofelemer’s potential inclusion in the EMA’s PRIME program for expediated and assisted regulatory approval and in the FDA’s Breakthrough Therapy program for expedited regulatory approval in the US, Jaguar’s expectation that additional proof-of-concept results from IITs will be available throughout 2025, and Jaguar’s expectation that published data from clinical investigations in MVID and SBS-IF could support reimbursed early patient access to crofelemer for MVID and SBS-IF. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:
hello@jaguar.health
Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

View the original press release on ACCESS Newswire

RALEIGH, NC / ACCESS Newswire / June 23, 2025 / iAccess Alpha’s Virtual Best Ideas Summer Investment Conference will take place on June 24-25, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities. The lineup has recently been updated to include additional presenters.

The event begins on Tuesday, June 24, 2025, with a series of live-streamed company presentations, beginning at 9:00 AM ET. The following day, Wednesday, June 25, will be dedicated to 1×1 meetings between presenting companies and investors, starting at 8:00 AM ET.

How to Attend:

Investors and industry professionals can register to watch the presentations and request 1×1 meetings by visiting the official event website: Register Here

Conference Schedule – June 24, 2025 (All Times ET):

Time	Company	Ticker	Webcast Link
9:00am	Inuvo Inc.	NYSE/AMEX:INUV	View Presentation
9:30am	Digi Power X Inc.	NASDAQ:DGXX /TSXV:DGX	View Presentation
10:00am	Surgepays Inc.	NASDAQ:SURG	View Presentation
10:30am	Coya Therapeutics Inc.	NASDAQ:COYA	View Presentation
11:00am	MIND Technoloy Inc.	NASDAQ:MIND	View Presentation
11:30am	Data IO Corp.	NASDAQ:DAIO	View Presentation
12:00pm	Gaia Inc.	NASDAQ:GAIA	View Presentation
12:30pm	Upexi Inc.	NASDAQ:UPXI	View Presentation
1:00pm	DocGo Inc.	NASDAQ:DCGO	View Presentation
1:30pm	SKYX Platforms Corp.	NASDAQ:SKYX	View Presentation
2:00pm	HeartBeam Inc.	NASDAQ:BEAT	View Presentation
2:30pm	Heritage Global Inc.	NASDAQ:HGBL	View Presentation
3:00pm	Mobilicom Ltd.	NASDAQ:MOB	View Presentation
3:30pm	Envela Corp.	NYSE/AMEX:ELA	View Presentation

About iAccess Alpha’s Virtual Best Ideas Investment Conferences

iAccess Alpha hosts four virtual investment conferences annually (March, June, September, and December), showcasing high-potential small and micro-cap investment opportunities. The conferences feature live company presentations on Day 1, followed by exclusive 1×1 investor meetings on Day 2. Since 2019, iAccess Alpha has co-organized leading microcap-focused events, connecting top-tier investors with high-potential companies.

For more information, contact:
info@iaccessalpha.com
www.iaccessalpha.com

SOURCE: iAccess Alpha

View the original press release on ACCESS Newswire

BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A H5N1 Quantitative Stock, a groundbreaking advancement in molecular diagnostic quality assurance. Leveraging phage-like particle encapsulated RNA technology, this product sets a new standard for accuracy and reliability in avian influenza (H5N1) detection, addressing critical gaps in laboratories’ ability to validate end-to-end testing workflows.

As H5N1 outbreaks continue to rise globally, the need for robust quality control materials has never been greater. ZeptoMetrix’s Influenza A H5N1 Quantitative Stock offers laboratories a comprehensive quality control material that requires RNA extraction, unlike traditional naked RNA products. This novel solution includes three encapsulated H5N1 gene segments within a phage-like particle, ensuring realistic validation of extraction, amplification, and detection steps.

“The ongoing H5N1 pandemic highlighted the urgent need for reliable diagnostic tools,” said Dr. Karuna Sharma, PhD, Vice President & Chief Scientific Officer of Antylia Diagnostics division. “This launch represents a significant advancement in diagnostic quality control. By encapsulating RNA within a phage-like particle, we enable labs to have confidence in their results at every step. This is not just innovation; it is vital in the fight against H5N1 and other emerging RNA viruses.”

NATtrol Influenza A H5N1 Quantitative Stock (Product Code: 0831198) is NATtrol inactivated to enhance stability and provided with precision quantification at 1,000,000 gene copies/mL of each gene segment, verified by digital PCR (dPCR). The ready-to-use 1 mL format integrates seamlessly with ZeptoMetrix’s -STQ product line, streamlining workflow adoption.

More information on how to order and additional ZeptoMetrix products can be found at: www.zeptometrix.com

About ZeptoMetrix®

ZeptoMetrix, an Antylia Scientific company, is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services, have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

Product Page: https://www.zeptometrix.com/us/en/nattrol-influenza-a-h5n1-quantitative-stock-1-x-10-ml-15355

Contact Information

Andrew Zenger
Global Product Manager
andrew.zenger@antylia.com
(716) 715-7417

SOURCE: ZeptoMetrix

View the original press release on ACCESS Newswire

MIAMI BEACH, FL / ACCESS Newswire / June 23, 2025 / LQR House Inc. (the “Company” or “LQR House”) (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, is pleased to announce a new marketing agreement with Whiplash Whiskey. Under the agreement, LQR House will launch a custom digital multi-platform marketing campaign. Such campaign is intended to support the summer debut of Whiplash’s latest product – a whipped cream-flavored whiskey.

Whiplash Whiskey described its products as redefining indulgence with a bold twist, combining the smoothness of premium whiskey with the nostalgic richness of whipped cream. It’s a spirit that blurs the line between dessert and drink, making it an ideal candidate for viral content and consumer intrigue.

LQR House will leverage its robust network of influencers, creators, and digital assets to position Whiplash Whiskey as a summer staple. The campaign will be executed through LQR House’s proprietary e-commerce platform, CWSpirits.com, with a focus on driving brand awareness, customer engagement, and direct-to-consumer sales.

“At LQR House, we look for brands that break through the noise, and Whiplash Whiskey is exactly that,” said Sean Dollinger, CEO of LQR House. “We believe that this product embodies the kind of innovation that resonates with today’s consumers-playful, unexpected, and built for shareability. We intend to amplify this launch through curated content, influencer storytelling, and high-conversion e-commerce strategies. We’re excited to help Whiplash make a bold entrance this summer.”

This collaboration continues LQR House’s mission to align with forward-thinking beverage brands that prioritize creativity, quality, and direct consumer connection. Whiplash Whiskey will be available for purchase on CWSpirits.com starting this summer.

About LQR House Inc.

LQR House intends to become a prominent force in the wine and spirits e-commerce sector, epitomized by its flagship alcohol marketplace, cwspirits.com. This platform seamlessly delivers a diverse range of emerging, premium, and luxury spirits, wines, and champagnes from esteemed retail partners like Country Wine & Spirits. Functioning as a technology-driven hub, LQR House utilizes software, data analytics, and artificial intelligence to elevate consumer experience. CWSpirits.com stands out as the go-to destination for modern, convenience-oriented shoppers, providing a curated selection of alcohol products delivered to homes across the United States. Beyond its role in an e-commerce sector, LQR House is a marketing agency with a specialized focus on the alcohol industry. The Company measures campaign success by directly correlating it with sales on CWSpirits.com, demonstrating a return on investment. Backed by an influential network of around 460 figures in the alcohol space, LQR House strategically drives traffic to CWSpirits.com, enhancing brand visibility. LQR House intends to disrupt the traditional landscape of the alcohol industry, driven by its dedication to providing an unparalleled online purchasing experience and delivering tailored marketing solutions.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Shareholders can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. Forward-looking statements contained in this press release are made only as of the date of this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in other reports and documents that the Company files from time to time with the United States Securities and Exchange Commission (the “SEC”). You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the headings “Risk Factors”. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in other reports and documents that the Company files from time to time with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. References and links to websites have been provided as a convenience, and the information contained on such websites has not been incorporated by reference into this press release.

Investor and Media Contact:
info@lqrhouse.com

SOURCE: LQR House

View the original press release on ACCESS Newswire